Clinical trials have shown that mechanical thrombectomy (MT) is associated with improved functional outcomes for patients with acute ischemic stroke presenting with proximal anterior circulation, large vessel occlusion, and salvageable brain tissue.
1-5 As a result, MT has become the standard of care for these patients since 2015.
1,6 The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) is a 10-point scoring system based on the extent of early ischemic changes detected on the baseline noncontrasted computed tomography scan, with a score of 10 indicating normal and 0 indicating ischemic changes in all of the regions included in the score.
7 Patients with an ASPECTS lower than 6 were excluded from most clinical trials
8; therefore, data about their outcomes remain scarce, and whether these patients could still achieve benefits from MT remains unknown.
4 The rationale behind excluding this group of patients stems from the knowledge that patients with a large core infarct at presentation are unlikely to benefit from reperfusion to the same degree as those with either a small core infarct or no core infarct.
9 However, the infarct size threshold for futility remains unknown.